Patient views on a proposed oral cancer screening technology

Abstract Brush cytology and telemedicine platforms are used with proven benefits in remote diagnosis of malignancies like cervical cancer. In low-resource settings access to the current standard of care, biopsy and histopathology grading of oral lesions, can be unfeasible. Risk stratifying early malignant and oral potentially malignant lesions can help instigate therapeutic treatment and improve prognosis. Therefore, a tele-cytology platform enabling remote connectivity to specialist centres may aid early detection of oral cancer. We outline head and neck (H&N) cancer patients’ views on an oral brush cytology investigation.